Economic Note examining how a countrywide public drug insurance monopoly would reduce coverage quality for a large number of Canadians and considerably increase public spending
Authors
- Pages
- 5
- Published in
- Canada
20.500.12592/7m0cn2x
19 Feb 2024
Accessing this content requires a membership
If your institution is a member, please log into Canada Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.